Ranolazine extended release is a useful adjunct in the treatment of chronic stable angina pectoris

ISSN： 1172-0360

Source： Drugs & Therapy Perspectives, Vol.23, Iss.1, 2007-01, pp. : 1-4

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Spotlight on Ranolazine in Chronic Stable Angina Pectoris

By Siddiqui M. Asif A. Keam Susan J.

American Journal of Cardiovascular Drugs, Vol. 6, Iss. 5, 2006-01 ,pp. : 357-359

Adis International

Access to resources Recommend Favorite

Ranolazine: A Review of its Use in Chronic Stable Angina Pectoris

By Siddiqui M. Asif A. Keam Susan J.

Drugs, Vol. 66, Iss. 5, 2006-01 ,pp. : 693-710

Adis International

Access to resources Recommend Favorite

Ranolazine: A Review of its Use in Chronic Stable Angina Pectoris

By Keating Gillian M.

Drugs, Vol. 68, Iss. 17, 2008-01 ,pp. : 2483-2503

Adis International

Access to resources Recommend Favorite

Ranolazine: a guide to its use in chronic stable angina pectoris

By Adis International Limited

Drugs & Therapy Perspectives, Vol. 25, Iss. 4, 2009-04 ,pp. : 1-4

Adis International

Access to resources Recommend Favorite

Stable Angina Pectoris: Current Medical Treatment

Current Pharmaceutical Design, Vol. 19, Iss. 9, 2013-03 ,pp. : 1569-1580

Bentham Science Publishers

Access to resources Recommend Favorite